Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Stemtech (STEK) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for Stemtech (STEK) over the last 6 years, with Q3 2025 value amounting to 14.91%.

  • Stemtech's EBITDA Margin rose 2038200.0% to 14.91% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.9%, marking a year-over-year increase of 2704100.0%. This contributed to the annual value of 81.25% for FY2024, which is 201800.0% up from last year.
  • As of Q3 2025, Stemtech's EBITDA Margin stood at 14.91%, which was up 2038200.0% from 55.76% recorded in Q2 2025.
  • In the past 5 years, Stemtech's EBITDA Margin registered a high of 1624.65% during Q3 2022, and its lowest value of 1925.71% during Q2 2022.
  • In the last 5 years, Stemtech's EBITDA Margin had a median value of 44.53% in 2021 and averaged 123.43%.
  • Over the last 5 years, Stemtech's EBITDA Margin had its largest YoY gain of 22621300bps in 2022, and its largest YoY loss of -18968800bps in 2022.
  • Over the past 5 years, Stemtech's EBITDA Margin (Quarter) stood at 44.53% in 2021, then skyrocketed by 81bps to 8.59% in 2022, then tumbled by -7402bps to 644.09% in 2023, then skyrocketed by 104bps to 27.85% in 2024, then plummeted by -154bps to 14.91% in 2025.
  • Its EBITDA Margin stands at 14.91% for Q3 2025, versus 55.76% for Q2 2025 and 89.09% for Q1 2025.